Jennifer Panganiban, MD
Assistant Professor of Clinical Pediatrics
Department: Pediatrics
Contact information
The Children's Hospital of Philadelphia
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Division of GI, Hepatology and Nutrition
34th and Civic Center Boulevard
Philadelphia, PA 19104
Office: 215-590-3630
Fax: 215-590-3606
Fax: 215-590-3606
Email:
panganibaj@email.chop.edu
panganibaj@email.chop.edu
Education:
BS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
MD
University of Santo Tomas, Manila, Philippines, 2005.
Permanent linkBS (Biology)
University of Santo Tomas, Manila, Philippines, 2001.
MD
University of Santo Tomas, Manila, Philippines, 2005.
Description of Clinical Expertise
https://www.chop.edu/centers-programs/non-alcoholic-fatty-liver-disease-clinichttps://www.chop.edu/conditions-diseases/non-alcoholic-fatty-liver-disease-nafld
https://www.chop.edu/news/childrens-hospital-philadelphia-celebrates-nashday
Selected Publications
Parks, E, Panganiban, J, Sarwer DB: Perspectives of adolescents with severe obesity on social media in preparation for weight loss surgery: a qualitative study. BMC Pediatrics 20(1): 96, Mar 2020.Kohut, T, Panganiban J: Lifestyle Intervention as the primary treatment for pediatric NAFLD. Clinical Liver Disease- accepted awaiting publication 2020.
Maqbool A, Parks EP, Shaikhkhalil A, Panganiban J, Mitchell J, Stallings VA.: Nutritional requirements. Nelson Textbook of Pediatrics (21st Edition). Kliegman RM, St Geme JW, et al. (eds.). Elsevier, 21st edition(303-321), 2020.
Suraj S, Panganiban J, Anupindi S: Imaging Modalities in Pediatric NAFLD. Clinical Liver Disease- accepted awaiting publication 2020.
Kohut, T, Panganiban J: Autoimmune antibodies in children with NAFLD. Poster accepted 6th World Congress June 2020 2020.
Kohut T1, Robbins J, Panganiban J.: Update on childhood/adolescent obesity and its sequela. Curr Opin Pediatr. 31(5): 645-653, Oct 2019.
Shapiro WL1,2,3, Yu EL1,3, Arin JC1, Murray KF4, Ali S5, Desai NK6, Xanthakos SA7,8, Lin HC9, Alkhouri N10,11, Abdou R12, Abrams SH13,14,15,16, Butler MW17, Faasse SA18,19, Gillis LA20, Hadley TA18, Jain AK21, Kavan M22, Kordy K23, Lee P24, Panganiban J25, Pohl JF22, Potter C26, Rudolph B27, Sundaram SS28,29, Joshi S1,30, Proudfoot JA31, Goyal NP1,3, Harlow KE1,3, Newton KP1,3, Schwimmer JB1,3.: Clinical Practice Approach to Nonalcoholic Fatty Liver Disease by Pediatric Gastroenterologists in the United States. J Pediatr Gastroenterol Nutr 68(2): 182-189, Feb 2019.
Kohout, T, Panganiban, J: THE USE OF TOPIRAMATE IN PEDIATRIC OBESITY AND NON-ALCOHOLIC FATTY LIVER DISEASE. Poster, NASPGHAN Annual Meeting Chicago, IL 2019.
Kohut, T, Panganiban J: Topamax in Pediatric Obesity. Poster, CHOP Clinical Research Day 2019.
Kohut, T, Proute, E, Panganiban, J: Weight-loss Effects of Topiramate in Youth With Obesity Poster, The Obesity Society- Obesity Week in Las Vegas, NV 2019.